Breckenridge Pharmaceutical Rolls Out Generic Equivalent Of Pfizer's Xeljanz
Benzinga · 6h ago
Share
Listen to the news
Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced the launch of Tofacitinib Tablets, the generic equivalent of Xeljanz® by Pfizer, in the disease-modifying antirheumatic drug category.
This launch reflects Breckenridge's continued commitment to expanding access to essential therapies for patients living with chronic inflammatory conditions, where treatment continuity, affordability, and reliable supply play a critical role in long-term disease management.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved